Vaxdyn Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 8


  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $608K

  • Investors
  • 8

Vaxdyn General Information


Developer of immunotherapies and vaccines designed to prevent infectious diseases. The company's vaccines use antigens, immunomodulators, nanoparticles, and monoclonal antibodies to fight bacterial infections, enabling doctors to decrease the impact of infections caused by drug-resistant pathogens on public health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Corporate Office
  • Parque Ciudad del Conocimiento. calle Manuel Manaute Humanes s/n.
  • Edificio central, despacho 6
  • 41704 Dos Hermanas
  • Spain
+34 606 00 00 00

Vaxdyn Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vaxdyn Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 07-Apr-2022 $608K 00.00 00.000 Completed Generating Revenue
3. Grant 07-Jul-2020 00.000 00.00 Completed Generating Revenue
2. Secondary Transaction - Private $1.2M Completed Startup
1. Seed Round 01-Jan-2016 $1.2M $1.2M Completed Startup
To view Vaxdyn’s complete valuation and funding history, request access »

Vaxdyn Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 000.00 000.00 00 000.00 00.000
Ordinary 0,000 000.00 000.00 00 000.00 0.000
To view Vaxdyn’s complete cap table history, request access »

Vaxdyn Executive Team (4)

Name Title Board Seat Contact Info
Juanjo Infante Ph.D Chief Executive Officer & President
Michael McConnell Ph.D Co-Founder and Chief Scientific Officer
Pilar Romero Ph.D Co-Founder & Advisor
You’re viewing 3 of 4 executive team members. Get the full list »

Vaxdyn Board Members (3)

Name Representing Role Since
Pilar Huerta Ph.D Self Board Member 000 0000
Ricardo Henriques Ph.D Bionova Capital Board Member 000 0000
Santiago Pla Arquimea Board Member 000 0000
To view Vaxdyn’s complete board members history, request access »

Vaxdyn Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vaxdyn Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Arquimea Corporation Minority 000 0000 000000 0
Bionova Capital Venture Capital Minority 000 0000 000000 0
Botín Foundation Accelerator/Incubator Minority 000 0000 000000 0
Laboratorio Reig Jofré Corporation Minority 000 0000 000000 0
Next Generation Asset Manager Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Vaxdyn FAQs

  • When was Vaxdyn founded?

    Vaxdyn was founded in 2011.

  • Who is the founder of Vaxdyn?

    Michael McConnell Ph.D and Pilar Romero Ph.D are the founders of Vaxdyn.

  • Who is the CEO of Vaxdyn?

    Juanjo Infante Ph.D is the CEO of Vaxdyn.

  • Where is Vaxdyn headquartered?

    Vaxdyn is headquartered in Dos Hermanas, Spain.

  • What is the size of Vaxdyn?

    Vaxdyn has 8 total employees.

  • What industry is Vaxdyn in?

    Vaxdyn’s primary industry is Drug Discovery.

  • Is Vaxdyn a private or public company?

    Vaxdyn is a Private company.

  • What is the current valuation of Vaxdyn?

    The current valuation of Vaxdyn is 00.000.

  • What is Vaxdyn’s current revenue?

    The current revenue for Vaxdyn is 00000.

  • How much funding has Vaxdyn raised over time?

    Vaxdyn has raised $1.8M.

  • Who are Vaxdyn’s investors?

    Arquimea, Bionova Capital, Botín Foundation, Laboratorio Reig Jofré, and Next Generation are 5 of 8 investors who have invested in Vaxdyn.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »